A previous study conducted in melanoma demonstrated that IL-6 could upregulate the expression levels of CCR5 in MDSC through the STAT pathway, thus promoting their recruitment in the tumor microenvironment (Weber et al., 2020). Here, IL6 is linked to melanoma.